PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Saint James School of Medicine, Arnos Vale, Saint Vincent and the Grenadines.\', \'University of Washington, Seattle, WA, USA.\', \'All Saints University School of Medicine, Roseau, Dominica.\', \'Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Tampa Bay Campus, Clearwater, FL, USA.\', \'Dr. Kiran C. Patel College of Osteopathic Medicine, Nova Southeastern University, Tampa Bay Campus, Clearwater, FL, USA. mparmar@nova.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1208/s12249-021-02058-y
?:hasPublicationType
?:journal
  • AAPS PharmSciTech
is ?:pmid of
?:pmid
?:pmid
  • 34100150
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.752
?:rankingScore_hIndex
  • 71
?:title
  • Tozinameran (BNT162b2) Vaccine: The Journey from Preclinical Research to Clinical Trials and Authorization.
?:type
?:year
  • 2021

Metadata

Anon_0  
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://purl.org/net/provenance/ns#DataItem>
<http://www.w3.org/1999/02/22-rdf-syntax-ns#type> <http://www.w3.org/2004/03/trix/rdfg-1/Graph>
<http://xmlns.com/foaf/0.1/primaryTopic> <https://research.tib.eu/covid-19/entity/34100150>
<http://xmlns.com/foaf/0.1/topic> Anon_0
<http://www.ontologydesignpatterns.org/cp/owl/informationrealization.owl#realizes> <https://research.tib.eu/covid-19/data/entity/34100150>
<http://purl.org/net/provenance/ns#createdBy>
Anon_1   (more)
expand all